Position in LH
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,472,000
-$2,134,478 QoQ
Shares Held
12,400
-41.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#295
of 1,045 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 54%
None 46%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026LEVIN CAPITAL STRATEGIES, L.P. holds $25,411,089 across 7 Diagnostics & Research names. LH ranks #3 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WAT |
Waters Corp /De/
|
26,520 | $9,946,060 | |
| 2 | DGX |
Quest Diagnostics Inc
|
24,000 | $5,086,800 | |
| 3 | LH |
Labcorp Holdings Inc.
This page
|
12,400 | $3,472,000 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
6,909 | $3,463,896 | |
| 5 | FLGT |
Fulgent Genetics, Inc.
|
105,542 | $2,165,721 | |
| 6 | RVTY |
Revvity, Inc.
|
7,772 | $864,712 | |
| 7 | WGS |
GeneDx Holdings Corp.
|
6,000 | $411,900 |
All Filings in LH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,472,000 | 12,400 | Shares | Other | 2026-07-31 | |
| 2026-03-31 | $5,606,478 | 21,013 | Shares | Other | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||